Curcumin reduces the level of epidermal growth factor receptor (EGFR), Akt, and matrix metalloproteinase (MMP2) while upregulating tissue inhibitors of metalloproteinase (TIMP-1) in breast cancer. This evidence concerns the gene EGFR and breast carcinoma.